ema prac naion semaglutide june 2025 and Eye Health: A Look at Risk Meeting highlights from the Pharmacovigilance

UK Delivery and Legal Context: Under UK law, semaglutide and tirzepatide are prescription-only medicines (POMs) when intended for human use, regulated by the Medicines and Healthcare products Regulatory Agency (MHRA)

a Key inclusion criteria for STEP 1, 35 and 8 trials were age 18 years, BMI 30 kg/m 2 or 27 kg/m 2 with 1 weightrelated comorbidity (treated or untreated): hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease, history of at least one selfreported unsuccessful dietary effort to lose weight and no type 1 or type 2 diabetes

Thankfully, this is rare and can usually be avoided with proper administration, dosing, and taking near mealtimes

Up to 15% Decrease in Weight - Guests typically experience an average weight reduction of up to 15%

- Have struggled to lose weight despite making healthy eating and activity changes

This $99 add-on test, available after your first month, personalizes your treatment approach